semaglutide average weight loss first month Understanding Dosage: Key Information Real-world data show weekly semaglutide

At SmileCon 2025 Kimberly Sanders, Pharm.D., an educator at the University of North Carolina, delivered a timely session titled, Bite-Sized Breakthroughs: How New diabetes and weight-Loss Medications Impact Care, where she discussed how the latest diabetes and weight-loss medications are reshaping patient care while highlighting what dental professionals need to know

Foundayo (orforglipron) , a new oral GLP-1, received FDA approval on April 1, 2026

Our approach includes: Comprehensive health evaluations before treatment Personalized dosing and ongoing monitoring Nutritional guidance tailored to your needs Recommendations for exercise and wellness support A supportive team to keep you on track By addressing the whole picture, not just the medication, we empower our patients to achieve lasting transformations

In all of that work, it was actually really important that we could show where the GLP-1 receptor was not expressed